Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Baillie

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Pharmaceutisch Weekblad. Scientific Edition|June 19, 1992
Metabolism of valproate to hepatotoxic intermediatesT A Baillie
Drug Metabolism Reviews|November 21, 2014
The contributions of Sidney D. Nelson to drug metabolism researchThomas A Baillie
Expert Opinion on Drug Discovery|October 2, 2020
Approaches to mitigate the risk of serious adverse reactions in covalent drug designThomas A Baillie
Chemical Research in Toxicology|July 18, 2006
Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicologyThomas A Baillie
Angewandte Chemie (International Ed. in English)|August 20, 2016
Targeted Covalent Inhibitors for Drug DesignThomas A Baillie
Chemical Research in Toxicology|February 17, 2009
Approaches to the assessment of stable and chemically reactive drug metabolites in early clinical trialsThomas A Baillie
Chemical Research in Toxicology|December 7, 2007
Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolismThomas A Baillie
Accounts of Chemical Research|September 20, 2013
Distinctive activation and functionalization of hydrocarbon C-H bonds initiated by Cp*W(NO)(η(3)-allyl)(CH2CMe3) complexesRhett A Baillie, Peter Legzdins
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparationsK Kassahun, T A Baillie
Science (New York, N.Y.)|March 20, 2004
Organic chemistry in drug discoveryMalcolm MacCoss, Thomas A Baillie
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Pharmaceutisch Weekblad. Scientific Edition|June 19, 1992
Metabolism of valproate to hepatotoxic intermediatesT A Baillie
Drug Metabolism Reviews|November 21, 2014
The contributions of Sidney D. Nelson to drug metabolism researchThomas A Baillie
Expert Opinion on Drug Discovery|October 2, 2020
Approaches to mitigate the risk of serious adverse reactions in covalent drug designThomas A Baillie
Chemical Research in Toxicology|July 18, 2006
Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicologyThomas A Baillie
Angewandte Chemie (International Ed. in English)|August 20, 2016
Targeted Covalent Inhibitors for Drug DesignThomas A Baillie
Chemical Research in Toxicology|February 17, 2009
Approaches to the assessment of stable and chemically reactive drug metabolites in early clinical trialsThomas A Baillie
Chemical Research in Toxicology|December 7, 2007
Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolismThomas A Baillie
Accounts of Chemical Research|September 20, 2013
Distinctive activation and functionalization of hydrocarbon C-H bonds initiated by Cp*W(NO)(η(3)-allyl)(CH2CMe3) complexesRhett A Baillie, Peter Legzdins
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparationsK Kassahun, T A Baillie
Science (New York, N.Y.)|March 20, 2004
Organic chemistry in drug discoveryMalcolm MacCoss, Thomas A Baillie
Pageof 21